• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗黑色素瘤分化相关基因5(抗MDA5)抗体阳性皮肌炎:不同种族患者队列的临床特征及预后

Antimelanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis: clinical features and outcomes in a racially diverse patient cohort.

作者信息

Koyoda Sai K, Ezzy Fatema, Wahezi Dawn, Kumthekar Anand, Xie Xianhong, Tagoe Clement E, Ayesha Bibi

机构信息

Montefiore Medical Center, Albert Einstein College of Medicine, Rheumatology, Bronx, NY, USA.

Jacobi Medical Center, Department of Internal Medicine, Bronx, NY, USA.

出版信息

BMC Rheumatol. 2025 Jan 9;9(1):5. doi: 10.1186/s41927-025-00455-5.

DOI:10.1186/s41927-025-00455-5
PMID:39789667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11715331/
Abstract

BACKGROUND

The anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis is known for its association with rapidly progressive interstitial lung disease (RP-ILD) and ulcerative skin lesions, often presenting with or without muscle involvement. The aim of this study was to identify distinct clinical and laboratory features that could be used to evaluate disease progression in an ethnically diverse cohort of anti-MDA5 dermatomyositis patients at a U.S. academic center.

METHODS

A retrospective chart review was conducted on dermatomyositis patients hospitalized at our institution between January 2014 and June 2023. The data were analyzed via Fischer's exact test and a t test.

RESULTS

Among the 195 dermatomyositis patients reviewed, 22 tested positive for the MDA5 antibody, comprising of thirteen adults and nine pediatric patients. Myositis was significantly more common in pediatric patients than in adult patients (p = 0.002). RP-ILD was more frequently observed in adult patients of African ancestry (including both Black Hispanic and Black non-Hispanic individuals) (p = 0.04). There was a significant association noted between Raynaud's phenomenon and ILD (p = 0.02). The overall mortality rate of 13.6% was more favorable than the previously reported rates of 40-60%.

CONCLUSION

This study enhances our understanding of the disease by emphasizing potential racial and demographic variations, as well as delineating the similarities and differences between adult and pediatric populations.

摘要

背景

抗黑色素瘤分化相关基因5(anti-MDA5)抗体阳性皮肌炎以其与快速进展性间质性肺病(RP-ILD)和溃疡性皮肤病变相关而闻名,常伴有或不伴有肌肉受累。本研究的目的是确定不同的临床和实验室特征,以用于评估美国一家学术中心不同种族队列的抗MDA5皮肌炎患者的疾病进展。

方法

对2014年1月至2023年6月在我们机构住院的皮肌炎患者进行回顾性病历审查。通过费舍尔精确检验和t检验对数据进行分析。

结果

在审查的195例皮肌炎患者中,22例MDA5抗体检测呈阳性,包括13例成人患者和9例儿科患者。肌炎在儿科患者中比在成人患者中更常见(p = 0.002)。RP-ILD在非洲裔成人患者(包括西班牙裔黑人及非西班牙裔黑人个体)中更常观察到(p = 0.04)。雷诺现象与ILD之间存在显著关联(p = 0.02)。13.6%的总死亡率比先前报道的40%-60%更有利。

结论

本研究通过强调潜在的种族和人口统计学差异,以及描绘成人和儿科人群之间的异同,增强了我们对该疾病的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653a/11715331/a5b80cb1c552/41927_2025_455_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653a/11715331/a5b80cb1c552/41927_2025_455_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653a/11715331/a5b80cb1c552/41927_2025_455_Fig1_HTML.jpg

相似文献

1
Antimelanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis: clinical features and outcomes in a racially diverse patient cohort.抗黑色素瘤分化相关基因5(抗MDA5)抗体阳性皮肌炎:不同种族患者队列的临床特征及预后
BMC Rheumatol. 2025 Jan 9;9(1):5. doi: 10.1186/s41927-025-00455-5.
2
Clinical features and prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease in Chinese patients.中国抗黑色素瘤分化相关基因 5 抗体阳性伴快速进展性间质性肺病的皮肌炎的临床特征和预后因素。
Immun Inflamm Dis. 2023 Jun;11(6):e882. doi: 10.1002/iid3.882.
3
Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study.临床无肌病性皮肌炎与经典皮肌炎特征及抗 MDA5 抗体分布和疗效比较:一项回顾性病例对照研究。
Front Immunol. 2023 Nov 27;14:1237209. doi: 10.3389/fimmu.2023.1237209. eCollection 2023.
4
The efficacy and safety of tofacitinib in anti-melanoma differentiation-associated gene 5 antibody positive dermatomyositis associated interstitial lung disease: a systematic review and meta-analysis.托法替布治疗抗黑色素瘤分化相关基因 5 抗体阳性皮肌炎相关间质性肺病的疗效和安全性:系统评价和荟萃分析。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241294000. doi: 10.1177/17534666241294000.
5
Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome.抗MDA5阳性皮肌炎和抗合成酶综合征中快速进展性间质性肺病的不同多变量危险因素。
Front Immunol. 2022 Mar 7;13:845988. doi: 10.3389/fimmu.2022.845988. eCollection 2022.
6
[Clinical characteristics and prognostic factors of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated interstitial lung disease].抗黑色素瘤分化相关基因5抗体阳性皮肌炎相关间质性肺疾病患者的临床特征及预后因素
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Aug 12;46(8):781-790. doi: 10.3760/cma.j.cn112147-20221017-00821.
7
Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.抗黑色素瘤分化相关基因5抗体阳性皮肌炎合并快速进展性间质性肺病的临床特征及不良预后因素
Eur J Dermatol. 2019 Oct 1;29(5):511-517. doi: 10.1684/ejd.2019.3634.
8
Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.伴或不伴肌炎相关自身抗体的临床无肌病性皮肌炎患者循环抗 MDA5 自身抗体的临床特征差异。
Respir Med. 2018 Jul;140:1-5. doi: 10.1016/j.rmed.2018.05.010. Epub 2018 May 22.
9
Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.加拿大抗黑色素瘤分化相关基因 5(MDA5)阳性皮肌炎患者的临床特征和治疗:基于病例的回顾性研究。
Rheumatol Int. 2019 Nov;39(11):1971-1981. doi: 10.1007/s00296-019-04398-2. Epub 2019 Aug 2.
10
Predictors of Poor Outcome of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease in a Chinese Cohort with Dermatomyositis.抗 MDA5 相关快速进展性间质性肺疾病在中国皮肌炎队列中的不良预后预测因素。
J Immunol Res. 2020 Nov 25;2020:2024869. doi: 10.1155/2020/2024869. eCollection 2020.

引用本文的文献

1
Integration of clinical and serological biomarkers in a nomogram for predicting interstitial lung disease in idiopathic inflammatory myopathies.临床和血清生物标志物在预测特发性炎性肌病间质性肺病的列线图中的整合。
BMC Rheumatol. 2025 Jul 1;9(1):73. doi: 10.1186/s41927-025-00534-7.

本文引用的文献

1
Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias.自身抗体阳性与特发性间质性肺炎患者的恶性肿瘤相关。
Biomedicines. 2022 Oct 2;10(10):2469. doi: 10.3390/biomedicines10102469.
2
Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis.抗 MDA5 阳性皮肌炎患者的性别和年龄相关死亡率差异。
Mod Rheumatol. 2023 Aug 25;33(5):975-981. doi: 10.1093/mr/roac091.
3
Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population.
特发性炎性肌病患者中与普通人群相比同期癌症高发的亚组。
Arthritis Rheumatol. 2023 Apr;75(4):620-629. doi: 10.1002/art.42311. Epub 2023 Feb 16.
4
Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk.抗MDA5抗体阳性皮肌炎中抗Ro52抗体的共存与快速进展性间质性肺病及死亡风险高度相关。
J Rheumatol. 2023 Feb;50(2):219-226. doi: 10.3899/jrheum.220139. Epub 2022 Jun 15.
5
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies.抗 MDA5 抗体相关性皮肌炎:生物临床特征、发病机制和新兴治疗方法。
Front Immunol. 2021 Oct 20;12:773352. doi: 10.3389/fimmu.2021.773352. eCollection 2021.
6
Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review.青少年发病的抗 MDA5 抗体阳性的少年皮肌炎伴快速进展性间质性肺病和自发性纵隔气肿:病例报告及文献复习。
Pediatr Rheumatol Online J. 2021 Jun 30;19(1):103. doi: 10.1186/s12969-021-00595-1.
7
Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies.肌炎自身抗体在不同种族的特发性炎性肌病患儿中的研究。
Pediatr Rheumatol Online J. 2021 Jun 12;19(1):92. doi: 10.1186/s12969-021-00574-6.
8
Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management.肌炎相关性间质性肺疾病:诊断与管理的综合方法。
Clin Exp Rheumatol. 2022 Feb;40(2):373-383. doi: 10.55563/clinexprheumatol/brvl1v. Epub 2021 Mar 25.
9
Predictors of Poor Outcome of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease in a Chinese Cohort with Dermatomyositis.抗 MDA5 相关快速进展性间质性肺疾病在中国皮肌炎队列中的不良预后预测因素。
J Immunol Res. 2020 Nov 25;2020:2024869. doi: 10.1155/2020/2024869. eCollection 2020.
10
Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.抗 MDA5 自身抗体与北美青少年皮肌炎相关,构成独特表型。
Rheumatology (Oxford). 2021 Apr 6;60(4):1839-1849. doi: 10.1093/rheumatology/keaa429.